Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Russo

Showing results (301-310 of 357) with videos related to

Pageof 36
Sort By:
Breast Cancer Research : BCR|December 3, 2020
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detectionClaudia Fredolini, Khyatiben V Pathak, Luisa Paris, et al.
BJU International|August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified studyKyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
Cancer|October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinomaA Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
Urologic Oncology|November 15, 2017
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutationsBrandon J Manley, Ed Reznik, Mazyar Ghanaat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
Urologic Oncology|December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinomaStephen W Reese, Lennert Eismann, Charlie White, et al.
Urologic Oncology|April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomyDaniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
European Urology Oncology|November 19, 2019
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive NephrectomyRenzo G DiNatale, Wanling Xie, Maria F Becerra, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
Urologic Oncology|September 9, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohortRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Pageof 36

Showing results (301-310 of 357) with videos related to

Sort By:
Pageof 36
Breast Cancer Research : BCR|December 3, 2020
Shotgun proteomics coupled to nanoparticle-based biomarker enrichment reveals a novel panel of extracellular matrix proteins as candidate serum protein biomarkers for early-stage breast cancer detectionClaudia Fredolini, Khyatiben V Pathak, Luisa Paris, et al.
BJU International|August 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified studyKyle A Blum, Andrew W Silagy, Andrea Knezevic, et al.
Cancer|October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinomaA Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
Urologic Oncology|November 15, 2017
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutationsBrandon J Manley, Ed Reznik, Mazyar Ghanaat, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
Urologic Oncology|December 22, 2023
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinomaStephen W Reese, Lennert Eismann, Charlie White, et al.
Urologic Oncology|April 15, 2017
Genomic alterations as predictors of survival among patients within a combined cohort with clear cell renal cell carcinoma undergoing cytoreductive nephrectomyDaniel M Tennenbaum, Brandon J Manley, Emily Zabor, et al.
European Urology Oncology|November 19, 2019
The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive NephrectomyRenzo G DiNatale, Wanling Xie, Maria F Becerra, et al.
Medrxiv : the Preprint Server for Health Sciences|May 2, 2025
Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell CarcinomaYash S Khandwala, Stephen W Reese, Burcin A Ucpinar, et al.
Urologic Oncology|September 9, 2020
Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohortRoy Mano, Cihan Duzgol, Maz Ganat, et al.
Pageof 36